<SEC-DOCUMENT>0001193125-17-372414-index.html : 20171219
<SEC-HEADER>0001193125-17-372414.hdr.sgml : 20171219
<ACCEPTANCE-DATETIME>20171218194147
ACCESSION NUMBER:		0001193125-17-372414
CONFORMED SUBMISSION TYPE:	S-3/A
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20171219
DATE AS OF CHANGE:		20171218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		S-3/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-221402
		FILM NUMBER:		171262574

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3/A
<SEQUENCE>1
<FILENAME>d489256ds3a.htm
<DESCRIPTION>FORM S-3/A
<TEXT>
Document 1 - file: d489256ds3a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>d489256dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
Document 2 - file: d489256dex42.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d489256dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: d489256dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>d489256dex121.htm
<DESCRIPTION>EX-12.1
<TEXT>
Document 4 - file: d489256dex121.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>d489256dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 5 - file: d489256dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>6
<FILENAME>d489256dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 6 - file: d489256dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g489256g84s99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: g489256g84s99.jpg

</DOCUMENT>
</SEC-DOCUMENT>